| GTO ID | GTC0775 |
| Trial ID | ChiCTR1800019449 |
| Disease | B-Cell Malignancy |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An open-label, single-center and single-arm clinical study for infusion of anti-CD20 CAR-T cells for patients with relapsed or refractory B-cell malignancies |
| Year | 2018 |
| Country | China |
| Company sponsor | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Cohort 1 | |||||||
|
|||||||